President Trump said Sunday that he would sign an executive order to base U.S. drug prices on what other countries pay — an ...

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

A proposal to require four years of emergency residency “threatens to burden future residents while failing to meaningfully ...

House Republicans are considering nixing a Medicaid drug-pricing plan floated by President Trump and fiercely opposed by ...

The FDA has approved the first cervical cancer testing kit that allows women to collect their own sample at home before ...

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

As Trump attacks on Harvard gain momentum, researchers are scrambling: "Everyone can read the writing on the wall." ...

DOGE lists just over 400 NIH contracts it says have been cancelled under its directive to reduce contract spending by 35% ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

Researchers calculated that $1.8 billion in National Institutes of Health grants were terminated in just over one month ...

Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...